Efficacy of buspirone in smoking cessation: a placebo-controlled trial (Q39461237)

12 September 2017

Efficacy of buspirone in smoking cessation: a placebo-controlled trial (English)

1 reference

12 September 2017

0 references

1 reference

Schneider NG

1

1 reference

12 September 2017

Olmstead RE

2

1 reference

12 September 2017

Steinberg C

3

1 reference

12 September 2017

Sloan K

4

1 reference

12 September 2017

Daims RM

5

1 reference

12 September 2017

Brown HV

6

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 November 1996

1 reference

Clinical Pharmacology & Therapeutics

12 September 2017

1 reference

12 September 2017

60

1 reference

12 September 2017

5

1 reference

12 September 2017

568-575

1 reference

Buspirone: an update on a unique anxiolytic agent

12 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990153-8

An Analysis of the Effectiveness of Interventions Intended to Help People Stop Smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990153-8

Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990153-8

Effectiveness of nicotine patch and nicotine gum as individual versus combined treatments for tobacco withdrawal symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990153-8

Buspirone and related compounds as alternative anxiolytics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990153-8

Nicotine vs. placebo gum in the alleviation of withdrawal during smoking cessation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990153-8

Nicotine replacement: ten-week effects on tobacco withdrawal symptoms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990153-8

Buspirone reduces smoking

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990153-8

Effect of buspirone on cigarette withdrawal symptoms and short-term abstinence rates in a smokers clinic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990153-8

Effect of Buspirone on Withdrawal Symptoms Associated With Smoking Cessation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990153-8

Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990153-8

A placebo-controlled evaluation of the effects of buspirone on smoking cessation: differences between high- and low-anxiety smokers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990153-8

Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990153-8

Predicting smoking cessation. Who will quit with and without the nicotine patch.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990153-8

10.1016/S0009-9236(96)90153-8

7 January 2021

Identifiers

DOI

1 reference

12 September 2017

1 reference